Annual Retained Earnings
-$513.21 M
-$30.04 M-6.22%
December 31, 2023
Summary
- As of February 8, 2025, RGLS annual retained earnings is -$513.21 million, with the most recent change of -$30.04 million (-6.22%) on December 31, 2023.
- During the last 3 years, RGLS annual retained earnings has fallen by -$86.17 million (-20.18%).
- RGLS annual retained earnings is now -1093.21% below its all-time high of -$43.01 million, reached on December 31, 2011.
Performance
RGLS Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$546.78 M
-$14.06 M-2.64%
September 30, 2024
Summary
- As of February 8, 2025, RGLS quarterly retained earnings is -$546.78 million, with the most recent change of -$14.06 million (-2.64%) on September 30, 2024.
- Over the past year, RGLS quarterly retained earnings has dropped by -$14.06 million (-2.64%).
- RGLS quarterly retained earnings is now -1171.26% below its all-time high of -$43.01 million, reached on December 31, 2011.
Performance
RGLS Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
RGLS Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.2% | -2.6% |
| 3 y3 years | -20.2% | -16.6% |
| 5 y5 years | -30.7% | -34.5% |
RGLS Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -12.8% | at low | -20.2% | at low |
| 5 y | 5-year | -24.8% | at low | -32.9% | at low |
| alltime | all time | -1093.2% | at low | -1171.3% | at low |
Regulus Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$546.78 M(+2.6%) |
| Jun 2024 | - | -$532.72 M(+2.1%) |
| Mar 2024 | - | -$521.68 M(+1.7%) |
| Dec 2023 | -$513.21 M(+6.2%) | -$513.21 M(+1.6%) |
| Sep 2023 | - | -$505.15 M(+1.6%) |
| Jun 2023 | - | -$497.33 M(+1.4%) |
| Mar 2023 | - | -$490.31 M(+1.5%) |
| Dec 2022 | -$483.18 M(+6.2%) | -$483.18 M(+1.4%) |
| Sep 2022 | - | -$476.38 M(+1.6%) |
| Jun 2022 | - | -$468.83 M(+1.6%) |
| Mar 2022 | - | -$461.57 M(+1.5%) |
| Dec 2021 | -$454.85 M(+6.5%) | -$454.85 M(+1.6%) |
| Sep 2021 | - | -$447.72 M(+2.0%) |
| Jun 2021 | - | -$439.09 M(+1.4%) |
| Mar 2021 | - | -$433.06 M(+1.4%) |
| Dec 2020 | -$427.05 M(+3.8%) | -$427.05 M(+0.3%) |
| Sep 2020 | - | -$425.72 M(+0.4%) |
| Jun 2020 | - | -$424.20 M(+1.7%) |
| Mar 2020 | - | -$417.25 M(+1.4%) |
| Dec 2019 | -$411.31 M(+4.7%) | -$411.31 M(+1.2%) |
| Sep 2019 | - | -$406.42 M(+1.4%) |
| Jun 2019 | - | -$401.00 M(+1.3%) |
| Mar 2019 | - | -$395.98 M(+0.8%) |
| Dec 2018 | -$392.72 M | -$392.72 M(+2.2%) |
| Sep 2018 | - | -$384.16 M(+2.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | -$373.89 M(+3.8%) |
| Mar 2018 | - | -$360.04 M(+4.1%) |
| Dec 2017 | -$345.86 M(+26.5%) | -$345.86 M(+4.4%) |
| Sep 2017 | - | -$331.41 M(+5.0%) |
| Jun 2017 | - | -$315.58 M(+7.4%) |
| Mar 2017 | - | -$293.97 M(+7.5%) |
| Dec 2016 | -$273.35 M(+42.7%) | -$273.35 M(+7.9%) |
| Sep 2016 | - | -$253.33 M(+8.3%) |
| Jun 2016 | - | -$233.81 M(+9.9%) |
| Mar 2016 | - | -$212.72 M(+11.1%) |
| Dec 2015 | -$191.51 M(+41.1%) | -$191.51 M(+3.9%) |
| Sep 2015 | - | -$184.29 M(+7.6%) |
| Jun 2015 | - | -$171.29 M(+14.0%) |
| Mar 2015 | - | -$150.25 M(+10.7%) |
| Dec 2014 | -$135.77 M(+71.7%) | -$135.77 M(+19.5%) |
| Sep 2014 | - | -$113.60 M(+9.4%) |
| Jun 2014 | - | -$103.80 M(+13.0%) |
| Mar 2014 | - | -$91.83 M(+16.1%) |
| Dec 2013 | -$79.09 M(+30.9%) | -$79.09 M(+2.5%) |
| Sep 2013 | - | -$77.16 M(+2.9%) |
| Jun 2013 | - | -$75.00 M(+10.9%) |
| Mar 2013 | - | -$67.65 M(+12.0%) |
| Dec 2012 | -$60.42 M(+40.5%) | -$60.42 M(+12.8%) |
| Sep 2012 | - | -$53.54 M(+11.9%) |
| Jun 2012 | - | -$47.86 M(+11.3%) |
| Dec 2011 | -$43.01 M | -$43.01 M |
FAQ
- What is Regulus Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Regulus Therapeutics?
- What is Regulus Therapeutics annual retained earnings year-on-year change?
- What is Regulus Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Regulus Therapeutics?
- What is Regulus Therapeutics quarterly retained earnings year-on-year change?
What is Regulus Therapeutics annual retained earnings?
The current annual retained earnings of RGLS is -$513.21 M
What is the all time high annual retained earnings for Regulus Therapeutics?
Regulus Therapeutics all-time high annual retained earnings is -$43.01 M
What is Regulus Therapeutics annual retained earnings year-on-year change?
Over the past year, RGLS annual retained earnings has changed by -$30.04 M (-6.22%)
What is Regulus Therapeutics quarterly retained earnings?
The current quarterly retained earnings of RGLS is -$546.78 M
What is the all time high quarterly retained earnings for Regulus Therapeutics?
Regulus Therapeutics all-time high quarterly retained earnings is -$43.01 M
What is Regulus Therapeutics quarterly retained earnings year-on-year change?
Over the past year, RGLS quarterly retained earnings has changed by -$14.06 M (-2.64%)